APA

Shuford W. W., Klussman K., Tritchler D. D., Loo D. T., Chalupny J., Siadak A. W., Brown T. J., Emswiler J., Raecho H., Larsen C. P., Pearson T. C., Ledbetter J. A., Aruffo A. & Mittler R. S. (19970801). 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. : The Journal of experimental medicine.

Chicago

Shuford W W, Klussman K, Tritchler D D, Loo D T, Chalupny J, Siadak A W, Brown T J, Emswiler J, Raecho H, Larsen C P, Pearson T C, Ledbetter J A, Aruffo A and Mittler R S. 19970801. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. : The Journal of experimental medicine.

Harvard

Shuford W. W., Klussman K., Tritchler D. D., Loo D. T., Chalupny J., Siadak A. W., Brown T. J., Emswiler J., Raecho H., Larsen C. P., Pearson T. C., Ledbetter J. A., Aruffo A. and Mittler R. S. (19970801). 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. : The Journal of experimental medicine.

MLA

Shuford W W, Klussman K, Tritchler D D, Loo D T, Chalupny J, Siadak A W, Brown T J, Emswiler J, Raecho H, Larsen C P, Pearson T C, Ledbetter J A, Aruffo A and Mittler R S. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. : The Journal of experimental medicine. 19970801.